Cardiovascular Devices industry is anticipated to register 13% CAGR between 2023 and 2032 due to expanding geriatric population base contributing to global.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a.